review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Kerry L Lee | Q62126414 |
Gervasio A Lamas | Q63253349 | ||
Ana Navas-Acien | Q28052843 | ||
Daniel B. Mark | Q38590165 | ||
P2860 | cites work | Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys | Q39281753 |
EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc | Q43856686 | ||
Lead, cadmium, smoking, and increased risk of peripheral arterial disease | Q44927082 | ||
Chelation therapy: overlooked in the treatment and prevention of diabetes complications? | Q46211806 | ||
The tomato effect. Rejection of highly efficacious therapies | Q47439794 | ||
Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial. | Q51131325 | ||
Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. | Q51630025 | ||
Enhancement of lead excretion in humans by disodium calcium ethylene-diamine tetraacetate. | Q53769883 | ||
EDTA treatment of intermittent claudication--a double-blind, placebo-controlled study | Q68085865 | ||
Effects of tobacco and whiskey on the cardiovascular system | Q73722187 | ||
Clinical evaluation of chelation therapy: is there any wheat amidst the chaff? | Q73939540 | ||
Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid | Q74282172 | ||
The treatment of coronary artery disease with disodium EDTA | Q76486198 | ||
Transition metals bind to glycated proteins forming redox active "glycochelates": implications for the pathogenesis of certain diabetic complications | Q77350647 | ||
Bone lead levels and blood pressure endpoints: a meta-analysis | Q81089351 | ||
Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis | Q82080546 | ||
Lead exposure and cardiovascular disease--a systematic review | Q22306125 | ||
The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues | Q22306127 | ||
Provocative chelation with DMSA and EDTA: evidence for differential access to lead storage sites | Q22306524 | ||
Environmental chemicals and DNA methylation in adults: a systematic review of the epidemiologic evidence | Q26827830 | ||
Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure | Q27023569 | ||
DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF | Q28383601 | ||
Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population | Q28386811 | ||
Secondhand tobacco smoke: a source of lead exposure in US children and adolescents | Q28390544 | ||
A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study | Q28391488 | ||
Cadmium exposure and clinical cardiovascular disease: a systematic review | Q28392725 | ||
Cadmium exposure and incident cardiovascular disease | Q28392939 | ||
Cadmium exposure and incident peripheral arterial disease | Q28395555 | ||
Reduction in cadmium exposure in the United States population, 1988-2008: the contribution of declining smoking rates | Q28396725 | ||
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial | Q33792060 | ||
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT) | Q33952145 | ||
Chelation therapy for ischemic heart disease: a randomized controlled trial | Q34110046 | ||
Implications of Klotho in vascular health and disease. | Q34780123 | ||
Design of the Trial to Assess Chelation Therapy (TACT) | Q35627506 | ||
Interplay of reactive oxygen species and nitric oxide in the pathogenesis of experimental lead-induced hypertension | Q36889227 | ||
Clinical review: The role of advanced glycation end products in progression and complications of diabetes | Q37053328 | ||
Cadmium levels in urine and mortality among U.S. adults | Q37112497 | ||
Role of oxidative stress in development of complications in diabetes | Q37681089 | ||
Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. | Q37705016 | ||
Unlocking the biology of RAGE in diabetic microvascular complications | Q38134924 | ||
Environmental factors in cardiovascular disease | Q38605998 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | chelation therapy | Q1069061 |
cardiovascular disease | Q389735 | ||
P304 | page(s) | 2411-8 | |
P577 | publication date | 2016-05-24 | |
P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
P1476 | title | Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy | |
P478 | volume | 67 |
Q52365157 | Cadmium exposure increases the risk of juvenile obesity: a human and zebrafish comparative study. |
Q91644130 | Changes in blood pressure associated with lead, manganese, and selenium in a Bangladeshi cohort |
Q47612151 | Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review |
Q39361634 | Chelation therapy in cardiovascular disease: an update |
Q88915669 | Chelation therapy to prevent diabetes-associated cardiovascular events |
Q39002320 | Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy |
Q50100071 | Declining exposures to lead and cadmium contribute to explaining the reduction of cardiovascular mortality in the US population, 1988-2004. |
Q91130174 | Effects of blood lead on coronary artery disease and its risk factors: a Mendelian Randomization study |
Q30244075 | Environmental Metals and Cardiovascular Disease in Adults: A Systematic Review Beyond Lead and Cadmium. |
Q89944550 | Heavy Metal Content in PolyfloralHoney and Potential Health Risk. A Case Study of Copșa Mică, Romania |
Q88477855 | Heavy metal exposure has adverse effects on the growth and development of preschool children |
Q37681981 | Hyperglycemia enhances arsenic-induced platelet and megakaryocyte activation |
Q52568731 | In silico epigenetics of metal exposure and subclinical atherosclerosis in middle aged men: pilot results from the Aragon Workers Health Study. |
Q30460349 | Lead poisoning in a 16-year-old girl: a case report and a review of the literature (CARE compliant) |
Q89559641 | Limb Preservation Using Edetate Disodium-based Chelation in Patients with Diabetes and Critical Limb Ischemia: An Open-label Pilot Study |
Q39418956 | Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part Series |
Search more.